65 i b, drugs, pharmaceuticals,&hematology related products, FSS contract award

Ended Awarded Last action

Contract number
36F79718D0363
Awardee
Awarding agency
Task orders
11

Award facts

Opportunity
  • M5Q50A03 Solicitation number
Last date to order 100% complete
IDV ceiling
$7,000,000.00
Award type
Multiple award
Who can order
All agencies
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Fixed Price with Economic Price Adjustment

Award details come from SAM.gov/FPDS.

About this IDV

Radius Health, Inc. was awarded a General Services Administration Federal Supply Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB) by the Department of Veterans Affairs Veterans Health Administration, with a ceiling value of $7 million and an ultimate completion date of February 28, 2026. The contract, awarded on February 15, 2018, operates as a multiple-award indefinite delivery vehicle with no set-aside provisions. Under this master schedule contract, Radius Health serves as the prime contractor supplying specialized pharmaceutical products, primarily abaloparatide injections used to treat osteoporosis-related conditions, to Veterans Integrated Service Networks across the United States. The contract was terminated by convenience on February 28, 2026, due to a new contract award. Radius Health operates as a for-profit pharmaceutical manufacturer registered in System for Award Management since May 2017, with no identified subcontractors on any delivery orders.

Delivery orders issued against this GSA schedule vehicle span from May 2021 through December 2022, with individual orders ranging from approximately $13,500 to $676,165 in value. Orders were issued to support VA Medical Centers and VA Health Administration facilities nationwide, with places of performance primarily located in Lake Mary, Florida; Waltham, Massachusetts; Boston, Massachusetts; and Tucson, Arizona. In addition to the GSA schedule contract, Radius Health holds a single-award Blanket Purchase Agreement valued at $18.5 million, awarded December 20, 2022, extending through December 19, 2026, specifically for Tymlos (abaloparatide) supply to support the VA's osteoporosis treatment requirements. The BPA includes provisions for pricing updates through fiscal year 2026, enabling the VA to issue firm fixed-price delivery orders as clinical demand dictates across the healthcare system's Consolidated Mail Outpatient Pharmacies and individual medical facilities.

Task orders

Show all 11

IDV awards

IDV Agency Ceiling Awarded
36E79723A0008 BPA for tymlos National Acquisition Center (VA) $18,500,000

Transactions

Action Obligated Date
Legal Contract Cancellation P00022 · Contract cancellation (due to new contract award) | termination effective 02-28-2026, terminated by convenience. $0
Supplemental Agreement for work within scope P00021 · Short-term extension (6 months) $0
Supplemental Agreement for work within scope P00020 · 2026 public law pricing updates $0
Supplemental Agreement for work within scope P00018 · 6-month contract extension $0
Supplemental Agreement for work within scope P00017 · Contract extension $0
Supplemental Agreement for work within scope P00016 · Public law 2025 updates $0
Supplemental Agreement for work within scope P00015 · Administrative change - ordering summary $0
Supplemental Agreement for work within scope P00014 · Product addition $0
Supplemental Agreement for work within scope P00013 · Short term EXT $0
Supplemental Agreement for work within scope P00012 · PL 2024 $0
Supplemental Agreement for work within scope P00011 · Admin $0
Supplemental Agreement for work within scope P00010 · Admin change $0
Supplemental Agreement for work within scope P00009 · Short term extension $0
Supplemental Agreement for work within scope P00008 · Bilateral agreement $0
Supplemental Agreement for work within scope P00007 · PL 2022 $0
Supplemental Agreement for work within scope P00006 · Admin change $0
Supplemental Agreement for work within scope P00005 · Public law pricing updates 2021 $0
Supplemental Agreement for work within scope P00004 · Admin change $0
Supplemental Agreement for work within scope P00003 · PL 2020 $0
Supplemental Agreement for work within scope P00002 · 2019 public law $0
Other Administrative Action P00001 · Administrative change $0
Original award $0
Show all 22

Quick answers

Who was awarded contract 36F79718D0363?

36F79718D0363 was awarded to Radius Health, Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on February 15, 2018.

How much is contract 36F79718D0363 worth?

36F79718D0363's own ceiling is $7,000,000.

How many orders have been placed under contract 36F79718D0363?

11 orders have been placed under 36F79718D0363, the latest on December 20, 2022.

Who can order from contract 36F79718D0363?

36F79718D0363 is a multiple award federal supply schedule. All agencies can place orders on it.

Is contract 36F79718D0363 part of a contract vehicle?

Yes. 36F79718D0363 is part of Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36F79718D0363 competed?

The extent of competition for 36F79718D0363 was full and open competition.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV